Platinum(IV) prodrug complex (Pt(IV) prodrug) (Pt(IV) prodrug)

Platinum(IV) prodrug complexes are octahedral metal-based compounds designed to improve the pharmacological profile and therapeutic index of traditional platinum(II) drugs like cisplatin and oxaliplatin. These complexes are characterized by their kinetic inertness, which allows them to resist premature degradation and off-target reactions in the systemic circulation (Hall et al., 2007, Prog Clin Biol Res). Upon entering the reducing environment of a cancer cell, the Pt(IV) center undergoes a two-electron reduction to release the active Pt(II) species along with two axial ligands. The resulting Pt(II) drug binds to genomic DNA, forming bulky adducts that distort the double helix, inhibit replication, and trigger programmed cell death (apoptosis). In research contexts, such as studies involving the HCT116 human colorectal carcinoma cell line—which is notably mismatch repair (MMR) deficient—these complexes are evaluated for their ability to bypass platinum resistance and deliver synergistic bioactive ligands (PubMed, PMID: 28432924). This "combination" approach allows for the simultaneous targeting of multiple pathways within a single therapeutic entity, potentially reducing the side effects associated with conventional platinum-based chemotherapy. The provided string "Combination Pt prodrug complexes – cellular cytotoxicity in HCT116 cells" refers to an experimental assay or study title rather than a specific biological target. The primary molecular target of the released active species is genomic DNA, where they form cross-links that impede replication and induce apoptosis (Johnstone et al., 2016, Chem Rev).

Other names

Pt(IV) complexesPlatinum(IV) anticancer agentsDual-action platinum prodrugsCombination platinum prodrugs

Intracellular reduction of the kinetically inert octahedral Pt(IV) center to a square-planar Pt(II) species, which then forms covalent intra-strand and inter-strand cross-links with genomic DNA, primarily at the N7 position of guanine residues, thereby inhibiting DNA replication and transcription (Johnstone et al., 2016, Chem Rev; Wexselblatt & Gibson, 2012, J Inorg Biochem).